Neri D - Search Results

1

An engineered 4-1BBL fusion protein with "activity on demand".

Mock J, Stringhini M, Villa A, Weller M, Weiss T, Neri D. Mock J, et al. Among authors: neri d. Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):31780-31788. doi: 10.1073/pnas.2013615117. Epub 2020 Nov 25. Proc Natl Acad Sci U S A. 2020. PMID: 33239441 Free PMC article.

2

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

Halin C, Rondini S, Nilsson F, Berndt A, Kosmehl H, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Nat Biotechnol. 2002 Mar;20(3):264-9. doi: 10.1038/nbt0302-264. Nat Biotechnol. 2002. PMID: 11875427

3

Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy.

Ebbinghaus C, Ronca R, Kaspar M, Grabulovski D, Berndt A, Kosmehl H, Zardi L, Neri D. Ebbinghaus C, et al. Among authors: neri d. Int J Cancer. 2005 Aug 20;116(2):304-13. doi: 10.1002/ijc.20952. Int J Cancer. 2005. PMID: 15800913

4

An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties.

Gafner V, Trachsel E, Neri D. Gafner V, et al. Among authors: neri d. Int J Cancer. 2006 Nov 1;119(9):2205-12. doi: 10.1002/ijc.22101. Int J Cancer. 2006. PMID: 16823838

5

The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.

Rybak JN, Roesli C, Kaspar M, Villa A, Neri D. Rybak JN, et al. Among authors: neri d. Cancer Res. 2007 Nov 15;67(22):10948-57. doi: 10.1158/0008-5472.CAN-07-1436. Cancer Res. 2007. PMID: 18006840

6

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.

Villa A, Trachsel E, Kaspar M, Schliemann C, Sommavilla R, Rybak JN, Rösli C, Borsi L, Neri D. Villa A, et al. Among authors: neri d. Int J Cancer. 2008 Jun 1;122(11):2405-13. doi: 10.1002/ijc.23408. Int J Cancer. 2008. PMID: 18271006

7

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.

Schliemann C, Palumbo A, Zuberbühler K, Villa A, Kaspar M, Trachsel E, Klapper W, Menssen HD, Neri D. Schliemann C, et al. Among authors: neri d. Blood. 2009 Mar 5;113(10):2275-83. doi: 10.1182/blood-2008-05-160747. Epub 2008 Nov 12. Blood. 2009. PMID: 19005180 Free article.

8

New strategy for the extension of the serum half-life of antibody fragments.

Trüssel S, Dumelin C, Frey K, Villa A, Buller F, Neri D. Trüssel S, et al. Among authors: neri d. Bioconjug Chem. 2009 Dec;20(12):2286-92. doi: 10.1021/bc9002772. Bioconjug Chem. 2009. PMID: 19916518

9

Design and construction of a naïve mouse antibody phage display library.

Sommavilla R, Lovato V, Villa A, Sgier D, Neri D. Sommavilla R, et al. Among authors: neri d. J Immunol Methods. 2010 Feb 28;353(1-2):31-43. doi: 10.1016/j.jim.2010.01.003. Epub 2010 Jan 18. J Immunol Methods. 2010. PMID: 20093119

10

Isolation of a small-molecule inhibitor of the antiapoptotic protein Bcl-xL from a DNA-encoded chemical library.

Melkko S, Mannocci L, Dumelin CE, Villa A, Sommavilla R, Zhang Y, Grütter MG, Keller N, Jermutus L, Jackson RH, Scheuermann J, Neri D. Melkko S, et al. Among authors: neri d. ChemMedChem. 2010 Apr 6;5(4):584-90. doi: 10.1002/cmdc.200900520. ChemMedChem. 2010. PMID: 20229565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters